East Hanover (United States)

Type: City
Name: East Hanover (United States)
Country: United States
Latitude: 40.82
Longitude: -74.370003
population: 12,194
First reported Aug 29 2014 - Updated Aug 30 2014 - 1 reports

United Therapeutics wins drug patent ruling, stock soars

Aug 29 (Reuters) - United Therapeutics Inc shares soared on Friday after the company won a court ruling in a patent dispute that blocks Novartis AG from selling a generic version of its best-selling Remodulin hypertension drug.In afternoon trading, United ... [Published CNBC - Aug 29 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Albright: About 'Newsboy,' Morven, Nabisco and Morro Castle

Photo taken in Oct. 2013 of the Morven Museum and Garden, which received the New Jersey Historical Commission's Award of Recognition in 2013. Morven Museum and Garden is located in Princeton, NJ. Trenton Times file photo. Trenton Times file photo Joseph ... [Published New Jersey Online - Aug 28 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

New Pre-Trial Research Findings from Novartis Outlined (Active immunotherapy options for Alzheimer's disease)

By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Current study results on Clinical Trials and Studies have been published. According to news reporting out of East Hanover, New Jersey , by NewsRx editors, research stated, "Alzheimer's disease ... [Published 4 Traders - Aug 28 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Highly Chemoselective O-Ethylation of N-Boc Amino Alcohols Using Phase Transfer Catalysis

Chemical and Analytical Development, Novartis Pharmaceuticals Corporation , One Health Plaza, East Hanover, New Jersey 07936, United States Org. Process Res. Dev. , Article ASAP DOI: 10.1021/op500242k Publication Date (Web): August 21, 2014 Copyright ... [Published Organic Process Research & Development - Aug 27 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Parshas Re’eh

New Jersey resident Herman “Hy” Goldman still showed up for work on Monday.  The reason why Mr. Goldman’s day at work is noteworthy is because this past weekend he celebrated his 101st birthday.  Aside from a brief absence to serve in the U.S. Army in ... [Published JewishinStLouis - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Mortgage CUSO Makes Inc. Magazine's Fastest Growing List

Symbionce Financial Solutions LLC, a mortgage services firm, was the only CUSO to make Inc. magazine’s 500|5000 list, a ranking of the nation's fastest-growing private companies.Those selected for the 2014 list were ranked according to percentage revenue ... [Published Credit Union Times - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Patent Issued for Safety Pen Needle Assembly Having Shield for Non-Patient End

By a News Reporter-Staff News Editor at Journal of Engineering -- According to news reporting originating from Alexandria, Virginia , by VerticalNews journalists, a patent by the inventors Zaiken, Eliot ( Covington, GA ); Richards, Stephen ( Holdrege, ... [Published 4 Traders - Aug 21 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

101-year-old working man has advice for you

EAST HANOVER, N.J. - "What am I going to do, sit around and grow old?"That's what New Jersey resident Herman Goldman rhetorically asked a television reporter who was doing a story on his 101st birthday this month.  There's apparently no quit in this ... [Published NewsNet 5 - Aug 19 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

NEW FINDINGS FROM NOVARTIS DESCRIBE ADVANCES IN DEMENTIA (LONG-TERM SAFETY OF RIVASTIGMINE IN PARKINSON DISEASE DEMENTIA : An Open-Label, Randomized...

New Findings from Novartis Describe Advances in Dementia (Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study)By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Current study results on Dementia ... [Published 4 Traders - Aug 14 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Novartis loses new bid to dismiss U.S. lawsuit over kickbacks

U.S. District Judge Colleen McMahon allowed the government to continue its False Claims Act case against the Swiss drugmaker over claims submitted to Medicare and some state Medicaid programs for Myfortic, used by patients with kidney transplants, and ... [Published NewsRT.co.uk - Aug 08 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Study Data from Novartis Update Knowledge of Heart Failure (An International Survey to Assess Referral Thresholds for Destination Therapy in...

Study Data from Novartis Update Knowledge of Heart Failure ( An International Survey to Assess Referral Thresholds for Destination Therapy in Non-Inotrope-Dependent Patients: Results of the CONSENSUS-DT Study)By a News Reporter-Staff News Editor at Clinical ... [Published 4 Traders - Aug 06 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 1 reports

Novartis personalized cell therapy CTL019 receives FDA Breakthrough Therapy designation

EAST HANOVER, N.J., July 7, 2014 /PRNewswire/ -- Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment ... [Published PR Newswire: Policy & Public Interest - Jul 07 2014]

Quotes

...had a tremendous impact on United Therapeutics' total revenues, revenue growth, financial performance, and market capitalization," Sheridan wrote. "Without the claimed features of the '117 patent, Remodulin would not be commercially viable."
...According to news reporting out of East Hanover, New Jersey , by NewsRx editors, research stated, "Alzheimer's disease (AD) is the most common cause of dementia and a major contributor to disability and dependency among older people. AD pathogenesis is associated with the accumulation of amyloid-beta protein (A beta) and/or hyperphosphorylated tau protein in the brain."
Reporters obtained the following quote from the background information supplied by the inventors: "Pen injectors are known in the prior art and typically include a dose-adjustment mechanism for setting a dose, for example of insulin, and a pen needle for insertion into a patient to allow proper drug administration. The pen needle should be single-use and replaced with each administered dose."

More Content

All (20) | News (18) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
United Therapeutics wins drug patent ruling, st... [Published CNBC - Aug 29 2014]
Albright: About 'Newsboy,' Morven, Nabisco and ... [Published New Jersey Online - Aug 28 2014]
New Pre-Trial Research Findings from Novartis O... [Published 4 Traders - Aug 28 2014]
Highly Chemoselective O-Ethylation of N-Boc Am... [Published Organic Process Research & Development - Aug 27 2014]
Parshas Re’eh [Published JewishinStLouis - Aug 21 2014]
Mortgage CUSO Makes Inc. Magazine's Fastest Gro... [Published Credit Union Times - Aug 21 2014]
Patent Issued for Safety Pen Needle Assembly Ha... [Published 4 Traders - Aug 21 2014]
BECTON DICKINSON : Patent Issued for Angled Ret... [Published 4 Traders - Aug 21 2014]
101-year-old working man has advice for you [Published NewsNet 5 - Aug 19 2014]
NEW FINDINGS FROM NOVARTIS DESCRIBE ADVANCES IN... [Published 4 Traders - Aug 14 2014]
Stuart named studio director at MADGI [Published New York Real Estate Journal - Aug 12 2014]
Novartis loses new bid to dismiss U.S. lawsuit ... [Published NewsRT.co.uk - Aug 08 2014]
Novartis loses new bid to dismiss U.S. lawsuit ... [Published Clusterstock - Aug 08 2014]
Study Data from Novartis Update Knowledge of He... [Published 4 Traders - Aug 06 2014]
MAGDI hires David Stuart, AIA, as Studio Direct... [Published Building Design Construction - Jul 29 2014]
Novartis personalized cell therapy CTL019 recei... [Published PR Newswire: Policy & Public Interest - Jul 07 2014]
Protection 1 Partners With Wounded Warriors Fam... [Published PRWeb - Jun 30 2014]
Novartis gains FDA approval for Zykadia first t... [Published BioPortfolio - Apr 29 2014]
Tissue engineering methods and compositions [Published PharmCast - Apr 22 2014]
Mondelez International to Invest $130 Million i... [Published PR Newswire - Feb 06 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Novartis loses new bid to dismiss U.S. lawsuit ... [Published Clusterstock - Aug 08 2014]
<p><img class="float_right" src="http://static6.businessinsider.com/image/53c78ada5afbd329788b4567-450-300/drugmaker-novartis-to-eke-out-more-cost-savings-to-lift-margins.jpg" border="0" alt="The logo of Swiss drugmaker Novartis is seen at its headquarters ...
Novartis personalized cell therapy CTL019 recei... [Published PR Newswire: Policy & Public Interest - Jul 07 2014]
EAST HANOVER, N.J., July 7, 2014 /PRNewswire/ -- Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.